Supplemental Table 5 from Imlunestrant Is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wild-Type and Mutant Breast Cancer
Authors:
- Shripad V. BhagwatSBShripad V. Bhagwat
- Cecilia MurCMCecilia Mur
- Matthew VandekoppleMVMatthew Vandekopple
- Baohui ZhaoBZBaohui Zhao
- Weihua ShenWSWeihua Shen
- Carlos MarugánCMCarlos Marugán
- Andrew CapenACAndrew Capen
- Lisa KindlerLKLisa Kindler
- Jennifer R. StephensJSJennifer R. Stephens
- Lysiane HuberLHLysiane Huber
- Mark A. CastanaresMCMark A. Castanares
- David Garcia-TapiaDGDavid Garcia-Tapia
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)